Scarica l'app Stockscreener
3.52
11.04%
0.35
Dopo l'orario di chiusura:
3.59
0.07
+1.99%
Precedente Chiudi:
$3.17
Aprire:
$3.22
Volume 24 ore:
172.42K
Relative Volume:
0.97
Capitalizzazione di mercato:
$73.86M
Reddito:
-
Utile/perdita netta:
$-94.11M
Rapporto P/E:
-0.5857
EPS:
-6.01
Flusso di cassa netto:
$-86.06M
1 W Prestazione:
+14.29%
1M Prestazione:
+39.68%
6M Prestazione:
-20.00%
1 anno Prestazione:
-48.39%
Intervallo 1D:
$3.18
$3.57
Intervallo di 1 settimana:
$2.9297
$3.57
Portata 52W:
$1.78
$8.56
Adverum Biotechnologies Inc Stock (ADVM) Company Profile
Nome
Adverum Biotechnologies Inc
Settore
Industria
Telefono
(650) 649-1004
Indirizzo
100 CARDINAL WAY, REDWOOD CITY, CA
Confronta ADVM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADVM
Adverum Biotechnologies Inc
|
3.52 | 66.52M | 0 | -94.11M | -86.06M | -6.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Adverum Biotechnologies Inc Stock (ADVM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-25 | Iniziato | Oppenheimer | Outperform |
| 2024-04-30 | Iniziato | H.C. Wainwright | Buy |
| 2022-07-07 | Aggiornamento | Truist | Hold → Buy |
| 2021-07-23 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-05-03 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-04-29 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2021-04-29 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-04-29 | Downgrade | Truist | Buy → Hold |
| 2020-12-16 | Iniziato | UBS | Neutral |
| 2020-11-12 | Aggiornamento | Raymond James | Underperform → Mkt Perform |
| 2020-06-26 | Downgrade | Raymond James | Mkt Perform → Underperform |
| 2020-05-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-05-05 | Aggiornamento | SunTrust | Hold → Buy |
| 2020-04-28 | Iniziato | Goldman | Buy |
| 2020-03-16 | Iniziato | SVB Leerink | Outperform |
| 2020-02-10 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2020-02-10 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2019-10-15 | Reiterato | Chardan Capital Markets | Neutral |
| 2019-09-13 | Reiterato | Chardan Capital Markets | Neutral |
| 2019-06-14 | Ripresa | Raymond James | Mkt Perform |
| 2018-11-02 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2018-11-02 | Downgrade | SunTrust | Buy → Hold |
| 2018-09-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-08-30 | Iniziato | SunTrust | Buy |
| 2018-02-15 | Ripresa | Piper Jaffray | Overweight |
| 2017-10-12 | Iniziato | Raymond James | Outperform |
Mostra tutto
Adverum Biotechnologies Inc Borsa (ADVM) Ultime notizie
Real time breakdown of Adverum Biotechnologies Inc. stock performance2025 Risk Factors & Low Risk High Reward Ideas - Newser
Key metrics from Adverum Biotechnologies Inc.’s quarterly dataQuarterly Trade Summary & Free Safe Entry Trade Signal Reports - Newser
Historical volatility pattern of Adverum Biotechnologies Inc. visualizedMarket Activity Recap & Weekly Momentum Picks - Newser
Ranking Adverum Biotechnologies Inc. among high performing stocks via toolsDollar Strength & Capital Efficiency Focused Ideas - Newser
Sentiment analysis tools applied to Adverum Biotechnologies Inc.Trade Analysis Summary & Scalable Portfolio Growth Ideas - Newser
How to use a screener to detect Adverum Biotechnologies Inc. breakouts2025 Big Picture & Safe Capital Growth Trade Ideas - Newser
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
How does Adverum Biotechnologies Inc. compare to its peers2025 Macro Impact & Verified Trade Idea Suggestions - خودرو بانک
Adverum Biotechnologies’ Talent Acquisition and Equity Incentive Strategy: A Catalyst for Long-Term Value Creation - AInvest
Decoding Adverum Biotechnologies’ Talent Strategy: How Inducement Grants Under Nasdaq Rule 5635(c)(4) Signal Confidence in Long-Term Growth and Innovation in Ocular Gene Therapy - AInvest
Adverum Biotechnologies announces inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
16,860 Stock Options at $3.08: Adverum Biotechnologies Awards Inducement Grants to New Hires - Stock Titan
What’s the analyst consensus on Adverum Biotechnologies Inc.Product Launch & Verified Momentum Stock Watchlist - خودرو بانک
Is Adverum Biotechnologies Inc. exposed to political riskWall Street Watch & Technical Buy Zone Confirmations - خودرو بانک
Using Bollinger Bands to evaluate Adverum Biotechnologies Inc.Index Update & Risk Controlled Daily Trade Plans - Newser
Risk adjusted return profile for Adverum Biotechnologies Inc. analyzedWeekly Trading Summary & Community Verified Trade Signals - Newser
What is the dividend yield of Adverum Biotechnologies Inc.Weekly Risk Summary & Free Fast Gain Swing Trade Alerts - خودرو بانک
Will Adverum Biotechnologies Inc. benefit from macro trendsMarket Rally & Long-Term Safe Investment Ideas - Newser
Will Adverum Biotechnologies Inc. rebound enough to break evenPortfolio Gains Summary & Fast Exit Strategy with Risk Control - Newser
Does Adverum Biotechnologies Inc. stock benefit from AI growth2025 Volume Leaders & Safe Entry Point Alerts - خودرو بانک
Will earnings trigger a reversal in Adverum Biotechnologies Inc.Weekly Stock Summary & High Accuracy Investment Entry Signals - Newser
Is Adverum Biotechnologies Inc. forming a bottoming base2025 Bull vs Bear & High Return Trade Opportunity Guides - Newser
What dividend growth rate does Adverum Biotechnologies Inc. offerJuly 2025 Gainers & Reliable Price Action Trade Plans - خودرو بانک
Trading Recap: Is Adverum Biotechnologies Inc. forming a breakout patternEarnings Growth Report & Weekly Breakout Opportunity Watchlist - خودرو بانک
Will Adverum Biotechnologies Inc. benefit from AI trendsPortfolio Gains Summary & Safe Swing Trade Setups - خودرو بانک
Applying Wyckoff theory to Adverum Biotechnologies Inc. stockWeekly Gains Summary & Weekly Watchlist for Consistent Profits - Newser
What is the long term forecast for Adverum Biotechnologies Inc. stockWeekly Trend Summary & Precise Swing Trade Alerts - khodrobank.com
Is a relief rally coming for Adverum Biotechnologies Inc. holdersJuly 2025 Big Picture & Free Long-Term Investment Growth Plans - Newser
Is Adverum Biotechnologies Inc. likely to announce a buybackJuly 2025 Closing Moves & Weekly High Conviction Trade Ideas - خودرو بانک
Is Adverum Biotechnologies Inc. showing insider buyingMarket Sentiment Report & Precise Trade Entry Recommendations - خودرو بانک
Is Adverum Biotechnologies Inc. stock bottoming outEarnings Miss & Expert Verified Movement Alerts - Newser
Buybacks Report: Will Adverum Biotechnologies Inc. benefit from current market trendsJuly 2025 Selloffs & Daily Entry Point Trade Alerts - خودرو بانک
Detecting support and resistance levels for Adverum Biotechnologies Inc.Portfolio Risk Summary & Entry and Exit Point Strategies - Newser
How to interpret RSI for Adverum Biotechnologies Inc. stockForecast Cut & Precise Buy Zone Identification - Newser
Adverum Biotechnologies Inc. stock prediction for this week2025 Geopolitical Influence & Real-Time Chart Pattern Alerts - Newser
Heatmap analysis for Adverum Biotechnologies Inc. and competitorsWeekly Stock Report & Risk Controlled Swing Alerts - Newser
Adverum Biotechnologies Inc Azioni (ADVM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):